Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.51NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XATNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.85NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.65NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BG.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.74NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.13.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAZNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EE.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.52NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.4.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.58NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.631NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.627NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.519NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.514NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.87NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAPNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.4.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.6.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.47.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DN.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used